Epigenetic regulator explains why some lung cancer patients become resistant to common therapeutics
Cellular biologists discover why some patients become resistant to standard treatments for nonsmall cell lung cancer.
Materials provided by Purdue University. Original written by Brittany Steff. Note: Content may be edited for style and length.
Source link aaaaa